Related Experiment Videos
HIV and the breast.
Benjamin E Gewurz1, Bruce J Dezube, Liron Pantanowitz
1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
The AIDS Reader
|August 23, 2005
Summary
HIV infection and HAART can change breast conditions, including infections, morphologic changes like gynecomastia or lipomastia, and malignancy. Treatment for HIV patients with breast cancer should align with that for HIV-negative individuals.
Area of Science:
- Oncology
- Infectious Diseases
- Endocrinology
Background:
- HIV infection and highly active antiretroviral therapy (HAART) can impact breast health.
- Conditions affecting the breast in HIV-infected individuals include infections, morphologic alterations, and malignancy.
- Atypical infections and gynecomastia are common presentations, with gynecomastia potentially linked to HAART or lipodystrophy.
Purpose of the Study:
- To outline the differential diagnosis of breast conditions in HIV-infected patients.
- To discuss the presentation and potential causes of gynecomastia and lipomastia in this population.
- To provide guidance on managing breast malignancy in HIV-infected individuals on HAART.
Main Methods:
- Review of clinical presentations and diagnostic considerations for breast diseases in HIV-infected patients.
- Discussion of the relationship between HIV, HAART, and specific breast conditions.
- Analysis of treatment strategies for breast malignancy in the context of HIV infection and viral load control.
Main Results:
- Breast conditions in HIV-infected individuals range from atypical infections to morphologic changes like gynecomastia and lipomastia.
- Gynecomastia may result from HAART or be associated with lipodystrophy (lipomastia).
- HIV-infected patients with malignancy and controlled viral loads should receive treatment comparable to HIV-negative patients.
Conclusions:
- Practitioners must consider a broad differential diagnosis for breast conditions in HIV-infected patients.
- Distinguishing true gynecomastia from lipomastia is important for accurate diagnosis and management.
- Effective management of HIV and viral load allows for comparable treatment of breast malignancy in HIV-positive and HIV-negative individuals.